Gilead Sciences Inc. said Wednesday it has hired Dr. Roy Baynes as its senior vice president, oncology therapeutics.
The Foster City-based biopharmaceutical company (NASDAQ:GILD) said Baynes is expected to report to Norbert Bischofberger, executive vice president, R&D and chief scientific officer, in his new role.
No comments:
Post a Comment